
Chris King joins Synovate Healthcare
pharmafile | November 22, 2010 | Appointment | Sales and Marketing | Chris King, Synovate Healthcare, appointment, sales and marketing
Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division.
He joins the global market research agency from Datamonitor, where he was a senior consultant.
Chris has previously worked with Novartis Vaccines and he also spent six years working at the British Columbia Cancer Research Centre.
At Synovate Healthcare, he will be directly responsible for leadership of the European Oncology Monitor and tasked with overseeing the daily operations, staff management and client servicing for the firm’s European Oncology Monitor business.
Jackie Ilacqua, senior VP and head of global oncology at Synovate, said: “We are very excited to have Chris join our team. His expertise gained from the British Columbia Cancer Research Centre, coupled with his experience both on the manufacturer and agency side, will lend nicely to his new responsibilities.
“Chris has a real enthusiasm for working with data and consulting with clients on their business challenges.”
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






